Interpreting Absolute and Relative Risk Reduction in the Context of Recent Cardiovascular Outcome Trials in Patients with Type 2 Diabetes

2021 ◽  
Vol 21 (11) ◽  
Author(s):  
David D. Berg ◽  
Ahmed A. Kolkailah ◽  
Ashish Sarraju ◽  
Anne Marie Kerchberger ◽  
Mahmoud Eljalby ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Relative Risk ◽  
Risk Reduction ◽  
Relative Risk Reduction ◽  
Cardiovascular Outcome ◽  
Cardiovascular Outcome Trials

Statistical Considerations for Cardiovascular Outcome Trials in Patients with Type 2 Diabetes Mellitus

2017 ◽  
Vol 9 (4) ◽  
pp. 347-360 ◽  
Author(s):  
Olga Marchenko ◽  
Qi Jiang ◽  
Christy Chuang-Stein ◽  
Cyrus Mehta ◽  
Mark Levenson ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Outcome ◽  
Cardiovascular Outcome Trials

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial

2013 ◽  
Vol 10 (4) ◽  
pp. 289-301 ◽  
Author(s):  
Julio Rosenstock ◽  
Nikolaus Marx ◽  
Steven E Kahn ◽  
Bernard Zinman ◽  
John J Kastelein ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Outcome ◽  
Active Comparator ◽  
Cardiovascular Outcome Trials

scholarly journals Shifting Paradigms in the Medical Management of Type 2 Diabetes: Reflections on Recent Cardiovascular Outcome Trials

2017 ◽  
Vol 32 (9) ◽  
pp. 1044-1051 ◽  
Author(s):  
Faramarz Ismail-Beigi ◽  
Etie Moghissi ◽  
Mikhail Kosiborod ◽  
Silvio E. Inzucchi
Keyword(s):  
Type 2 Diabetes ◽  
Medical Management ◽  
Cardiovascular Outcome ◽  
Cardiovascular Outcome Trials
Sign in / Sign up

Export Citation Format

Share Document